Drug
Men1112
Men1112: highest development phase Phase 1, developed by Menarini. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Menarini
Trials
| Drug | Phase | Indication |
|---|---|---|
| MEN1112 NCT02353143 | Phase 1 | Recurrent Adult Acute Myeloid Leukemia |
Latest
No recent events.
Follow Men1112 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.